These diverse mechanisms of action of cannabinoids may serve as a potential therapy in case of triple negative melanomas (harboring wild-type BRAF, NRAS and PTEN), which do not respond to a novel immunotherapy. The gene discussed is PTEN; the disease is melanoma.